Athenex, Inc.
ATNXDelisted Jul 10, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001300699
Athenex, Inc. was delisted on Jul 10, 2023; its insiders filed their last Form 4 on May 8, 2023; 30 institutions reported holding it in 13F filings for Q1 2023, worth $2.43M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Athenex, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Athenex, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Lau Johnson Yiu Nam | CEO and Chairman of the Board | 250,397 | May 8, 2023 | 0 |
| Kwan Rudolf | EVP, Chief Medical Officer | 49,816 | May 8, 2023 | 0 |
| Cook Timothy DeVere | See Remarks | 4,140 | May 8, 2023 | 0 |
| Vierling John | Director | 12,329 | Apr 24, 2023 | 0 |
| Wu Jinn | Director | 34,802 | Apr 24, 2023 | 0 |
| Spiegel Robert J. | Director | 4,592 | Apr 24, 2023 | 0 |
| Fok Manson | Director | 110,675 | Apr 24, 2023 | 0 |
| TSANG Benson Kwan Hung | Director | 16,920 | Apr 24, 2023 | 0 |
| Davis Stephanie A | Director | 8,015 | Apr 24, 2023 | 0 |
| Annoni Joe | Chief Financial Officer | 375 | Feb 27, 2023 | 0 |
| Lang Daniel | Pres Cell Therapy, VP Corp Dev | 81,590 | Sep 19, 2022 | 0 |
| Kanfer Jordan | Director | 17,086 | Aug 30, 2022 | 0 |
| Yordon Jeffrey | See Remarks | 245,943 | Aug 15, 2022 | 0 |
| Smolinski Michael | Chief Scientific Officer | – | Jan 10, 2022 | 0 |
| Adams Steven J. | Interim Chief Acct Officer | – | Aug 17, 2021 | 0 |
| Campbell Kim | Director | – | Aug 5, 2021 | 0 |
| Pedder Simon | See Remarks | – | Aug 5, 2021 | 0 |
| Zuo William Wei | President, China Division | – | Aug 5, 2021 | 0 |
| Bair Teresa Brophy | General Counsel, SVP Admin. | – | Aug 5, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 30, 2022 (view filing)6:20 PM ET | Aug 22 | 8 daysLate | Wu JinnDirector | PPurchase | +10.0K | $0.4221 | +$4.22K | +2.1%484.8K after | |
| Aug 19, 2022 (view filing)4:25 PM ET | Aug 19 | Same day | Lau Johnson Yiu NamCEO and Chairman of the Board | PPurchase | +20.0K | $0.4549 | +$9.10K | +0.6%3.55M after | |
| Nov 22, 2021 (view filing) | Nov 22 | Same day | Lau Johnson Yiu NamCEO and Chairman of the Board | PPurchase | +3.00K | $1.84 | +$5.52K | +0.1%3.27M after | |
| Nov 18, 2021 (view filing) | Nov 18 | Same day | Lau Johnson Yiu NamCEO and Chairman of the Board | PPurchase | +3.00K | $1.87 | +$5.61K | +0.1%3.27M after | |
| Nov 18, 2021 (view filing) | Nov 17 | 1 day | Kanfer JordanDirector | PPurchase | +4.95K | $2.02 | +$10.0K | +106.9%9.59K after | |
| Nov 17, 2021 (view filing) | Nov 16 | 1 day | Kwan RudolfEVP, Chief Medical Officer | PPurchase | +4.00K | $2.05 | +$8.20K | +2.4%173.6K after | |
| Nov 17, 2021 (view filing) | Nov 17 | Same day | Wu JinnDirector | PPurchase | +30.0K | $2.03 | +$60.9K | +7.4%433.2K after | 2 lots |
| Nov 16, 2021 (view filing) | Nov 16 | Same day | Lau Johnson Yiu NamCEO and Chairman of the Board | PPurchase | +3.00K | $2.06 | +$6.18K | +0.1%3.27M after | |
| Nov 15, 2021 (view filing) | Nov 15 | Same day | Lau Johnson Yiu NamCEO and Chairman of the Board | PPurchase | +5.00K | $2.12 | +$10.6K | +0.2%3.27M after | |
| Nov 12, 2021 (view filing) | Nov 12 | Same day | Lau Johnson Yiu NamCEO and Chairman of the Board | PPurchase | +10.0K | $2.07 | +$20.7K | +0.3%3.26M after | |
| Oct 13, 2021 (view filing) | Oct 1 | 12 daysLate | Wu JinnDirector | PPurchase | +10.0K | $2.67 | +$26.7K | +2.5%413.2K after | |
| Sep 14, 2021 (view filing) | Sep 14 | Same day | Wu JinnDirector | PPurchase | +50.0K | $3.22 | +$161.0K | +14.2%403.2K after |